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clinics of a regional hospital in southern Taiwan. Outpatients with type 2 diabetes
were invited to participate the interviews for measuring QoL. After finishing the
TTO exercise for measuring QoL, a semi-structured interview was followed to ex-
plore participant’s view on themethods and specific attributes for trading off. TTO
results were transformed to utility value, and interviews were recorded, tran-
scribed verbatim and analyzed by constant comparison approach to saturation.
RESULTS:Of all, 96 of the 100 participants completed the TTO (mean age: 55.811.0
years, 54.2% male) the average utility is 0.6920.217, yet most participants (n68,
70.8%) accepted current health status and life expectancy and were reluctant to
give up any life years to exchange a full health. At interviews, participants revealed
their worries, anxiety, discomfort and disturbances of daily life related to diabetes,
but those factors were not considered when trading life year and health status
during TTO exercise; instead, satisfaction of life expectancy, child-caring and self-
recognition on values of life were considered. Information provided by healthcare
providers, peer supports and religions were found to help patients cope with the
disease and improve health-related QoL. CONCLUSIONS: For patients with
chronic, stable diabetes, an adaptation process may have diluted the impacts of
patients’ concerns on health-related QoL, and hence trading on life years and
health status is inappropriate to measure QoL utility. Further study is to explore
feasibility of TTO at different stages of diabetic complications, and cross-validate
between TTO and other utility measures.
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OBJECTIVES: Quality-of-life (QoL) is increasingly recognized as an important out-
comemeasure that provides information on the burden of diabetes on the physical,
mental and social aspects of patients’ health. To pick up disease-related changes in
QoL of diabetes patients in Korea, we administered Korean Audit of Diabetes-
Dependent Quality-of-Life (KR-ADDQoL) instrument. METHODS: A prospective,
observational study was carried out on type 2 diabetic patients from the diabetic
clinics of 24medical centers throughout Korea. A total of 413 diabetic patients aged
40 years and over were assessed for Health-Related QoL (HRQoL). HRQoL was as-
sessedwith KR-ADDQoL instrument. RESULTS: Patients with diabetes were 589.7
years old (47.2% female), had diabetes for 7.06.2 years. Themean present QoLwas
0.40.97 (range: 3 [extremely bad] to 3 [excellent]) and diabetes-dependent QoL
was 1.50.98 (range: 3 [very much better] to 1 [worse]). Patients with diabetes
and those with hypertension reported lower present QoL, compared with diabetes
only (0.31.01, 0.60.85; p0.0161). The mean KR-ADDQoL average weighted im-
pact (AWI) score was 2.41.8. Patients with 15-20 years of diabetes reported sig-
nificantly worse AWI scores (3.71.6) compared with those with 10-15 years
(1.91.5). A negative impact of diabetes was seen in all the dimensions of KR-
ADDQoL. Freedom to eat and people’s reaction remained as the most (mean AWI
scores: 4.32.8) and least (1.32.1) affected QoL domains, respectively, when
weighting was considered. CONCLUSIONS: Type 2 diabetes has a negative impact
in HRQoL in the patients studied. The findings highlighted the impact of diabetes
on QoL with particular reference to the effects on freedom to eat, and freedom to
drink. Our study contributed to the knowledge of QoL in Korean patients with type
2 diabetes by using a diabetes-specific QoL instrument. These findings suggest that
the impact of diabetes in QoL among Asian is similar [ADDQoL AWI score in Sin-
gaporeans: 2.61.9].
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OBJECTIVES: We assessed medication beliefs and evaluated association between
race andmedication beliefs among low-incomeAfricanAmericans andCaucasians
with diabetes. METHODS: A cross-sectional self-administered written survey of
Type 2 diabetes patients was conducted at a primary-care clinic affiliated with a
hospital serving an urban population. Inclusion criteria were being 18 years or
older, diagnosed with Type 2 diabetes at least 6 months prior to the time of the
survey, and taking oral anti-diabetic medication. Exclusion criteria were use of
insulin or inability to read and write in English. The survey included the Beliefs
about Medications Questionnaire to assess individuals’ medication beliefs. Analy-
sis of variance was used to compare differences in medication beliefs across race.
RESULTS: Usable responses were obtained from 236 of 397 individuals who satis-
fied inclusion and exclusion criteria, for a response rate of 59%. The sample was
53% African American, 47% Caucasian, 63% female and 72% had annual household
income of less than $25,000. A majority (63%) had at most completed high school
education. Mean belief scores for necessity of taking diabetes medications were
higher for Caucasians (3.74) than for African Americans (3.49) (p0.0396) after ad-
justing for age, gender, education, time since diabetes diagnosis, number of med-
ications taken for diabetes and total medications taken for all conditions. Mean
scores for perceived harm from medications were higher for African Americans
(2.55) than Caucasians (2.29) (p0.0162). Mean scores for perceived overuse ofmed-
icines by prescribers were higher for African Americans (3.32) as compared to Cau-
casians (3.04) (p0.0497). CONCLUSIONS: Small differences in medication beliefs
between African Americans and Caucasians were observed after adjusting for
other covariates. Exploration of the role of medication beliefs in racial disparities
may be informative.
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OBJECTIVES: Individuals with diabetes type 2 usually show low compliance with
secondary prevention measures. Economic theory states that, from the demand
side, insurance reduces the incentives for individuals to claim self-protection and
hence, increases the ex-ante moral hazard while in the other hand, it selects indi-
viduals with lower risk preferences. This analysis aims to determine the net effect
of contributory and subsidized insurance on preventive effort in individuals un-
dergoing diabetes in Colombia. METHODS: Using data from the National Health
Survey-2007,we selected individuals aged between 18-69 andpreviously diagnosed
with diabetes (n  1446). We performed an instrumental variables model by treat-
ing the choice of insurance as endogenous and using self-employment and the
proportion of individuals insured under either contributory and subsidized regi-
mens in the municipality as instruments. In this analysis we present marginal
effects. RESULTS: We found evidence that, controlling for all covariates, health
insurance increases prevention care in individuals under the Contributory regimen
(0.259; SE 0,126) in comparison to uninsured individuals; however, for those en-
rolled in the Subsidized regimen the results were not significantly different when
comparing to uninsured individuals(0.047; SE 0.113). CONCLUSIONS: The internal-
ization of costs by health insurers throughout the life of individuals suffering from
diabetes is essential to improve secondary prevention in diabetes in the country. In
this case, we found that, unlike the Subsidized Regimen, the more comprehensive
benefits plan in the Contributory scheme is likely to increase the cost faced by the
insurer, encouraging it to promote preventive activities among individuals with
diabetes. This finding has important policy implications given the rapid growth in
health care costs to treat diabetes in Colombia. These results are easily inferred for
other preventable chronic conditions such as chronic obstructive pulmonary dis-
ease, heart disease and hypertension.
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OBJECTIVES: To review the variety of diabetes risk assessment tools and their
validity METHODS: An electronic literature search of the EMBASE, MEDLINE,
Cochrane library was undertaken using key words ‘diabetes risk’ and screening
or assessment or score or questionnaire, ‘diabetes prediction’, ‘medical screen-
ing’, and ‘health risk assessment’ from 1995-2010. References of identified arti-
cles were also manually searched. RESULTS: The electronic search retrieved a
total of 2168 articles reporting diabetes risk questionnaires. Deletion of duplicates
by Endnote andmanual culling produced a list of 41 questionnaires developed in 22
countries, with the majority (n26) developed in North America and Europe; the
remainder were from Asia (n10), Middle-East (n3), Africa (n1) and Austra-
lia(n1). Of the 41 questionnaires, 17 were developed for screening of undiagnosed
diabetes and 24 for predicting the risk of developing disease in the next 2-20 years.
All identified tools are short questionnaires of 2-16 questions with common vari-
ables of diabetes risk factor such as age, gender, waist circumference, BMI, family
history of diabetes, history of hypertension or antihypertensive medications being
used for risk assessment.While scoring format and cutoff points are diverse across
the questionnaires, the overall sensitivity, specificity, area under receiver operat-
ing characteristic curve (ROC) ranged from 40-97% and 24-86% and 62-87% respec-
tively. Comparatively speaking, there weremore tools developed for predicting the
risk of developing disease in recent years. CONCLUSIONS: There is a trend of
increasing availability of diabetes prediction tools with the existing diabetes risk
assessment tools being generally short questionnaire aiming for ease of use in
clinical practice. The overall performance of existing tools showed moderate to
high accuracy in their predictive performance. However, there are not enough
reports about their application in real-life clinical settings to allow an assessment
of their effectiveness in routine practice.
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OBJECTIVES: To identify patterns of antidiabetic drug prescribing in established
type 2 diabetes mellitus, to assess compliance of prescribing patterns with current
evidences and to describe determinants of the choice of antidiabetic drugs.
METHODS: Patients with established T2DM who attended the endocrinology Out-
patient Clinic in Postgraduate Institute of Medical Education and Research, Chan-
digarh, India were evaluated in a retrospective observational manner. Patients
were examined for social, demographical and clinical variables and medications.
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